Literature DB >> 19482279

Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: final results of an international multicenter, randomized, controlled trial.

Burr J Loew1, Douglas A Howell, Michael K Sanders, David J Desilets, Paul P Kortan, Gary R May, Raj J Shah, Yang K Chen, Willis G Parsons, Robert H Hawes, Peter B Cotton, Adam A Slivka, Jawad Ahmad, Glen A Lehman, Stuart Sherman, Horst Neuhaus, Brigitte M Schumacher.   

Abstract

BACKGROUND: The Wallstent has remained the industry standard for biliary self-expanding metal stents (SEMSs). Recently, stents of differing designs, compositions, and diameters have been developed.
OBJECTIVE: To compare the new nitinol 6-mm and 10-mm Zilver stents with the 10-mm stainless steel Wallstent and determine the mechanism of obstruction.
DESIGN: Randomized, prospective, controlled study.
SETTING: Nine centers experienced in SEMS placement during ERCP. PATIENTS: A total of 241 patients presenting between September 2003 and December 2005 with unresectable malignant biliary strictures at least 2 cm distal to the bifurcation. MAIN OUTCOME MEASUREMENT: Stent occlusions requiring reintervention and death.
RESULTS: At interim analysis, a significant increase in occlusions was noted in the 6-mm Zilver group at the P = .04 level, resulting in arm closure but continued follow-up. Final study arms were 64, 88, and 89 patients receiving a 6-mm Zilver, 10-mm Zilver, and 10-mm Wallstent, respectively. Stent occlusions occurred in 25 (39.1%) of the patients in the 6-mm Zilver arm, 21 (23.9%) of the patients in the 10-mm Zilver arm, and 19 (21.4%) of the patients in the 10-mm Wallstent arm (P = .02). The mean number of days of stent patency were 142.9, 185.8, and 186.7, respectively (P = .057). No differences were noted in secondary endpoints, and the study was ended at the 95% censored study endpoints. Biopsy specimens of ingrowth occlusive tissue revealed that 56% were caused by benign epithelial hyperplasia.
CONCLUSIONS: SEMS occlusions were much more frequent with a 6-mm diameter SEMS and equivalent in the two 10-mm arms despite major differences in stent design, material, and expansion, suggesting that diameter is the critical feature. Malignant tumor ingrowth produced only a minority of the documented occlusions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19482279     DOI: 10.1016/j.gie.2008.11.018

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  32 in total

1.  Endoscopy: Nitinol self-expanding metal stents--safe and effective?

Authors:  Rahul Pannala; Andrew S Ross
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-12-06       Impact factor: 46.802

Review 2.  Drug eluting biliary stents to decrease stent failure rates: A review of the literature.

Authors:  Joseph Shatzel; Jisoo Kim; Kartik Sampath; Sharjeel Syed; Jennifer Saad; Zilla H Hussain; Kabir Mody; J Marc Pipas; Stuart Gordon; Timothy Gardner; Richard I Rothstein
Journal:  World J Gastrointest Endosc       Date:  2016-01-25

3.  Risk factors for pancreatitis following transpapillary self-expandable metal stent placement.

Authors:  Kazumichi Kawakubo; Hiroyuki Isayama; Yousuke Nakai; Osamu Togawa; Naoki Sasahira; Hirofumi Kogure; Takashi Sasaki; Saburo Matsubara; Natsuyo Yamamoto; Kenji Hirano; Takeshi Tsujino; Nobuo Toda; Minoru Tada; Masao Omata; Kazuhiko Koike
Journal:  Surg Endosc       Date:  2011-10-20       Impact factor: 4.584

4.  A multicenter prospective study of the short-term outcome of a newly developed partially covered self-expandable metallic biliary stent (WallFlex(®)).

Authors:  Takayoshi Tsuchiya; Takao Itoi; Takuji Gotoda; Kensuke Kuraoka; Atsushi Sofuni; Fumihide Itokawa; Toshio Kurihara; Kentaro Ishii; Shujiro Tsuji; Nobuhito Ikeuchi; Reina Tanaka; Junko Umeda; Fuminori Moriyasu
Journal:  Dig Dis Sci       Date:  2011-02-06       Impact factor: 3.199

5.  Impact of Radiofrequency Ablation on Malignant Biliary Strictures: Results of a Collaborative Registry.

Authors:  Reem Z Sharaiha; Amrita Sethi; Kristen R Weaver; Tamas A Gonda; Raj J Shah; Norio Fukami; Prashant Kedia; Nikhil A Kumta; Carlos M Rondon Clavo; Michael D Saunders; Jorge Cerecedo-Rodriguez; Paola Figueroa Barojas; Jessica L Widmer; Monica Gaidhane; William R Brugge; Michel Kahaleh
Journal:  Dig Dis Sci       Date:  2015-02-21       Impact factor: 3.199

6.  Covered stents versus uncovered stents for the palliation of malignant extrahepatic biliary obstruction caused by direct tumor invasion: a cohort comparative study.

Authors:  Feng Li; Feng Wang; Xinshun Yang; Donghua Ji; Jun Li; Ningfang Wang; Yongsheng Liu; Cheng Li; Tao Zhang; Ke Li
Journal:  Med Oncol       Date:  2012-03-04       Impact factor: 3.064

7.  Partially Covered Versus Uncovered Self-Expandable Metal Stents: Coating Nor Diameter Affect Clinical Outcomes.

Authors:  S P Shamah; C G Chapman; H Haider; C Liao; I Waxman; U D Siddiqui
Journal:  Dig Dis Sci       Date:  2019-04-30       Impact factor: 3.199

Review 8.  Towards the optimization of management of hepatocellular carcinoma.

Authors:  Xi Feng; Madhava Pai; Malkhaz Mizandari; Tinatin Chikovani; Duncan Spalding; Long Jiao; Nagy Habib
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

9.  A prospective randomized study for efficacy of an uncovered double bare metal stent compared to a single bare metal stent in malignant biliary obstruction.

Authors:  Hyun Jik Lee; Moon Jae Chung; Jeong Yup Park; Seung Woo Park; Chung Mo Nam; Si Young Song; Seungmin Bang
Journal:  Surg Endosc       Date:  2016-11-18       Impact factor: 4.584

10.  Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?

Authors:  Reem Z Sharaiha; Nikola Natov; Kati S Glockenberg; Jessica Widmer; Monica Gaidhane; Michel Kahaleh
Journal:  Dig Dis Sci       Date:  2014-07-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.